Analysts expect Harmony Biosciences Holdings, Inc. to report revenue of 285.18 M for Q3 26, against a range of 266.30 M to 304.06 M. The most recent reported quarter, Q2 26, came in at 261.28 M, a 9.7% beat against the 238.07 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 186.04 M | 201.27 M | 184.73 M | 200.49 M | 239.46 M | 243.78 M | 215.39 M | 261.28 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 209.36 M | 201.72 M | 183.06 M | 216.28 M | 250.83 M | 240.84 M | 230.58 M | 256.30 M | 304.06 M | 290.63 M | 295.61 M | 325.13 M | 369.95 M | 370.18 M | 276.25 M | 358.83 M | ||||||||||
| Low Estimate | 172.98 M | 174.61 M | 168.57 M | 178.43 M | 231.14 M | 216.18 M | 201.08 M | 219.84 M | 266.30 M | 237.82 M | 243.43 M | 298.24 M | 306.77 M | 304.01 M | 251.96 M | 299.12 M | ||||||||||
| Consensus Estimate | 191.17 M | 188.16 M | 175.81 M | 197.36 M | 240.98 M | 228.51 M | 215.83 M | 238.07 M | 285.18 M | 264.22 M | 269.52 M | 311.68 M | 338.36 M | 337.09 M | 264.11 M | 328.98 M |
Analysts expect Harmony Biosciences Holdings, Inc. to report earnings per share of 1.16 for Q3 26, against a range of 1.04 to 1.28. The most recent reported quarter, Q2 26, came in at 1.28, a 40.7% beat against the 0.91 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.79 | 0.85 | 0.78 | 0.68 | 0.87 | 0.38 | 0.55 | 1.28 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.75 | 0.80 | 0.62 | 0.76 | 0.87 | 0.94 | 0.79 | 0.94 | 1.28 | 1.04 | 0.92 | 1.14 | 1.17 | 1.34 | 1.05 | 1.30 | ||||||||||
| Low Estimate | 0.63 | 0.76 | 0.54 | 0.70 | 0.71 | 0.78 | 0.67 | 0.88 | 1.04 | 0.96 | 0.86 | 1.02 | 1.05 | 1.14 | 0.99 | 1.16 | ||||||||||
| Consensus Estimate | 0.69 | 0.78 | 0.58 | 0.73 | 0.79 | 0.86 | 0.73 | 0.91 | 1.16 | 1.00 | 0.89 | 1.08 | 1.11 | 1.24 | 1.02 | 1.23 |
Pull Wall Street consensus for Harmony Biosciences Holdings, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=HRMY&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "HRMY", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=HRMY&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();